@prefix jvr: <http://data.loterre.fr/ark:/67375/JVR> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix mesh: <http://id.nlm.nih.gov/mesh/vocab#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .

jvr:-BT300B3G-Q
  skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-L6C0XPHT-4
  skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-HVPDJNXG-V
  mesh:allowableQualifier jvr:-HQRFT0C6-B, jvr:-W6SQV79N-S, jvr:-NKM836P1-M, jvr:-T9HQD7ST-J, jvr:-Q3979798-W, jvr:-FWD2BGQ0-9, jvr:-BT300B3G-Q, jvr:-NB0XHT3S-N, jvr:-L6C0XPHT-4, jvr:-D0F21513-5, jvr:-R3QWLHRG-V, jvr:-WK5F724J-1, jvr:-SBNWSM1T-R, jvr:-S0CS1X5R-5, jvr:-XV06LPML-W, jvr:-THHNVC7V-3, jvr:-CB30NGKB-3, jvr:-G4R176S9-J, jvr:-NHL3D2X0-S, jvr:-G30ZJ446-J, jvr:-H7K65Q8S-Z, jvr:-M63HSDM7-1, jvr:-R0ZCQ8X6-J, jvr:-NFTHND7Q-8, jvr:-TJHVZCRZ-0 ;
  dc:modified "2016-07-01"^^xsd:date ;
  dc:established "1973-01-01"^^xsd:date ;
  skos:inScheme jvr: ;
  skos:altLabel "WK2KZM9V6X"@fr, "WK2KZM9V6X"@en, "Acetoxythymoxamine"@en, "54-32-0 (Moxisylyte)"@fr, "54-32-0 (Moxisylyte)"@en, "PW8QYA7KI0"@fr, "PW8QYA7KI0"@en, "Thymoxamine"@en, "Phenol, 4-(2-(dimethylamino)ethoxy)-2-methyl-5-(1-methylethyl)-, acetate (ester)"@fr, "Phenol, 4-(2-(dimethylamino)ethoxy)-2-methyl-5-(1-methylethyl)-, acetate (ester)"@en, "Thymoxyalcylamine"@en ;
  skos:prefLabel "Moxisylyte"@en, "Moxisylyte"@fr ;
  skos:hiddenLabel "Moxisylyte Hydrochloride"@en, "Icavex"@en, "Carlytène"@en, "Chlorhydrate de moxisylyte"@fr ;
  mesh:pharmacologicalAction jvr:-X079LVDZ-K, jvr:-K9FBN5C5-1, jvr:-JHRKFGLJ-J, jvr:-BLDG6WP6-H ;
  skos:broader jvr:-RN6HDZL9-3 ;
  a skos:Concept, mesh:Descriptor ;
  skos:definition "An alpha-adrenergic blocking agent that is used in Raynaud's disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1312)"@en ;
  owl:sameAs <http://id.nlm.nih.gov/mesh/D013948> ;
  dc:created "1999-01-01"^^xsd:date .

jvr:-XV06LPML-W
  skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-Q3979798-W
  skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-H7K65Q8S-Z
  skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-TJHVZCRZ-0
  skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-G30ZJ446-J
  skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NFTHND7Q-8
  skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-FWD2BGQ0-9
  skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-BLDG6WP6-H
  skos:prefLabel "Adrenergic alpha-Antagonists"@en, "Antagonistes alpha-adrénergiques"@fr ;
  a mesh:Descriptor, skos:Concept .

jvr:-THHNVC7V-3
  skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-R0ZCQ8X6-J
  skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-S0CS1X5R-5
  skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-M63HSDM7-1
  skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-HQRFT0C6-B
  skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NB0XHT3S-N
  skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-W6SQV79N-S
  skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-CB30NGKB-3
  skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-G4R176S9-J
  skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr: a skos:ConceptScheme .
jvr:-SBNWSM1T-R
  skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-K9FBN5C5-1
  skos:prefLabel "Vasodilator Agents"@en, "Vasodilatateurs"@fr ;
  a mesh:Descriptor, skos:Concept .

jvr:-X079LVDZ-K
  skos:prefLabel "Miotics"@en, "Myotiques"@fr ;
  a mesh:Descriptor, skos:Concept .

jvr:-D0F21513-5
  skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-R3QWLHRG-V
  skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NHL3D2X0-S
  skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-T9HQD7ST-J
  skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-RN6HDZL9-3
  skos:prefLabel "Dimethylamines"@en, "Diméthylamines"@fr ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-HVPDJNXG-V .

jvr:-JHRKFGLJ-J
  skos:prefLabel "Sympatholytiques"@fr, "Sympatholytics"@en ;
  a mesh:Descriptor, skos:Concept .

jvr:-NKM836P1-M
  skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-WK5F724J-1
  skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .